STOCK TITAN

AbbVie to Present at the Evercore ISI Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on December 2, 2021, at 11:10 a.m. CT. Key executives, including Michael Severino, Robert A. Michael, and Jeffrey R. Stewart, will present. A live audio webcast will be available on AbbVie’s Investor Relations website, with an archived edition accessible later that day. AbbVie aims to discover innovative medicines to address serious health issues across various therapeutic areas, including immunology and oncology.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Nov. 23, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 11:10 a.m. CT.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-evercore-isi-conference-301430236.html

SOURCE AbbVie

FAQ

What will AbbVie present at the Evercore ISI Conference on December 2, 2021?

AbbVie will present its latest developments and strategies at the 4th Annual Evercore ISI Virtual HealthCONx Conference.

Who are the key speakers at AbbVie's presentation on December 2, 2021?

The presentation will feature Michael Severino, Robert A. Michael, and Jeffrey R. Stewart.

Where can I access the AbbVie presentation from the Evercore ISI Conference?

The presentation will be accessible via a live audio webcast on AbbVie’s Investor Relations website.

When will the AbbVie presentation at the Evercore ISI Conference take place?

AbbVie's presentation is scheduled for 11:10 a.m. CT on December 2, 2021.

What areas does AbbVie focus on for innovative medicines?

AbbVie focuses on therapeutic areas such as immunology, oncology, neuroscience, and more.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

292.69B
1.77B
0.09%
73.43%
0.92%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO